FDA approves EPOPROSTENOL SODIUM from GLAND FDA Approval Dec. 31, 2025, 13:45 UTC Final approval of ANDA #ANDA #219237 for EPOPROSTENOL SODIUM. Decision date: 12/29/2025 Full text
There are no comments here yet...